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Volume 59, Number 2 Abstracts 563and no statin use (HR, 3.41; P ¼ .006) at baseline. The rate of stroke
referable to contralateral progression was 5.6% (6 of 107).
Conclusions: Restenosis and contralateral carotid stenosis after CEA
progress signiﬁcantly after 5 years, with possible impact on surveillance stra-
tegies. Restenosis was not associated with closure technique. Statin use re-
duces new symptoms but not the rate of disease progression.
Fig. Freedom from restenosis and contralateral progression of
ICA stenosis following CEA.
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Objectives: Carotid endarterectomy (CEA) is currently performed by
various surgical specialties with varying outcomes. This study analyzes
different surgical practice patterns and their impact on perioperative stroke
and cost.
Methods: This is a retrospective analysis of prospectively collected
data of 1000 consecutive CEAs performed at our institution by three
different specialties: general surgeons (GS), cardiothoracic surgeons (CT),
and vascular surgeons (VS).
Results: A total of 474 CEAs were done by VS, 404 by CT, and
122 by GS.VS tended to operate more often on symptomatic patients
than CT and GS: 40% vs 23% and 31%, respectively (P < .0001). Preop-
erative workups were signiﬁcantly different between specialties: duplex ul-
trasound (DUS) only in 66%, 30%, and 18%; DUS and CTA in 27%, 35%,
and 29%; DUS and MRA in 6%, 35%, and 52% for VS, CT, and GS,
respectively (P < .001). The mean preoperative carotid stenosis was not
signiﬁcantly different between the specialties. The mean heparin dosage
was 5168, 7522, and 5331 units (P ¼ .0001), and protamine was used
in 0.2%, 19%, and 8% (P < .0001) for VS, CT, and GS, respectively. Post-
operative drains were used more often by VS; however, there was no as-
sociation between heparin dosage, protamine, and drain use and
postoperative bleeding. Patching was used in 99%, 93%, and 76% (P <
.0001) for VS, CT, and GS. Bovine pericardial patches were used more
often by CT, and ACUSEAL (Gore) patches were used more often by
VS (P < .0001). The perioperative stroke/death rates were 1.27% for
VS and 3.04% for CT and GS combined (P ¼ .055); and for asymptom-
atic patients, 0.7% for VS and 3.02% for CT and GS combined (P < .034).
Perioperative stroke rates for patients who had preoperative DUS only
were 0.88% vs 3.29% for patients who had extra imaging (computed to-
mography/magnetic resonance angiography; P ¼ .009); and for asymp-
tomatic patients, it was 0.94% vs 3.01% (P ¼ .05). When applying
hospital billing charges for preoperative imaging workups (cost of DUS
only vs DUS and other imaging), the VS practice pattern would have
saved $1180 per CEA over CT and GS practice patterns; a total savings
of $1,180,000 in this series.
Conclusions: CEA practice patterns differ between specialties.
Although the cost was higher for non-VS practices, the perioperative
stroke/death rate was somewhat higher. Therefore, educating physicians
who perform CEAs on cost-saving measures may be appropriate.A Propensity Score Matched Analysis of Asymptomatic Patients
Undergoing Carotid Endarterectomy (CEA) vs Coronary Artery
Bypass Graft (CABG) vs Combined CEA-CABG in the ACS-NSQIP
Li Wang, BS, Thomas Curran, MD, John C. McCallum, MD, Dominique
Buck, MD, Jeremy Darling, BA, Mark Wyers, MD, Raul J. Guzman, MD,
Allen Hamdan, MD, Elliot Chaikof, MD, PhD, Marc L.
Schermerhorn, MD. Beth Israel Deaconess Medical Center, Boston, Mass
Objectives: Carotid endarterectomy (CEA) and coronary artery
bypass grafting (CABG) may be combined to treat concomitant coronary
artery and carotid artery atherosclerotic disease. Previous reports on com-
bined CEA/CABG have shown wide variation in adverse event rates for
asymptomatic patients and have often been limited by small sample size
or lack of granularity, or both. We aim to compare stroke and death after
CEA/CABG with CEA or CABG alone in asymptomatic patients by using
the American College of Surgeons (ACS) National Surgical Quality
Improvement Program (NSQIP) database.
Methods: All patients undergoing CEA, CABG, or CEA/CABG
from 2005 to 2011 in the NSQIP database were identiﬁed. NSQIP-docu-
mented neurologic symptoms lack laterality and temporal detail for assign-
ment of positive current neurologic symptoms, whereas asymptomatic
patients are captured with excellent accuracy. Accordingly, only asymptom-
atic patients were analyzed. Propensity score matched groups of asymptom-
atic patients were based on age, sex, and American Society of
Anesthesiologists class 4. Analysis of variance, c2, and multivariable logistic
regression were used to compare stroke, death, and combined stroke/death
across procedures.
Results: We identiﬁed 47,667 patients: 42,474 CEA (89%), 5018
CABG (11%), and 175 CEA/CABG (<1%). Forty percent of all patients
had a history of neurologic symptoms and were omitted from consideration:
43% CEA, 12% CABG, and 28% CEA-CABG. Unmatched rates of stroke/
death in asymptomatic patients were 1.4% (CEA), 3.3% (CABG), and 6.7%
(CEA/CABG). Propensity score matching identiﬁed 1332 asymptomatic
patients: 606 CEA, 607 CABG, and 119 CEA/CABG. Stroke, death,
and stroke/death rates are compared across procedures in the Table. In-
dependent risk factors for stroke/death among matched asymptomatic
patients were recent myocardial infarction (odds ratio [OR], 4.0; 95%
conﬁdence interval [CI], 2.0-8.0), COPD (OR, 4.7l; 95% CI, 2.4-9.2), and
age >70 years (OR, 2.7; 95% CI, 1.4-5.2). CEA/CABG compared with
CABG alone did not have increased risk of stroke/death (OR, 6; 95% CI,
0.2-1.4). No signiﬁcant difference was seen between the stroke/death rate
of CEA/CABG (6.7%) compared with the aggregate of CEA and CABG
alone (2.1% + 4.2%).
Conclusions: In asymptomatic patients, CEA/CABG does not
confer an increased risk for stroke/death compared with the combined
risk of CEA and CABG alone. CEA/CABG should be considered a safe
approach in asymptomatic patients requiring CEA and CABG.
Table. Propensity score matched group outcome comparison
CEA CABG CEA-CABG PVariable (n ¼ 606) (n ¼ 607) (n ¼ 119) (CABG vs CEA/CABG)Death, % 1.2 2.3 3.4 .516
Stroke, % 1.2 2.0 3.4 .314
Stroke/
death, %
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Objectives: Long-term hemodialysis patients are a difﬁcult patient
population because they have few remaining access options and may have
disadvantaged vasculature in the upper extremities. Because of the increased
infection rate with femoral access, surgeons may place an axillary artery-to-
axillary vein arteriovenous graft (AAAVg). Few outcome reports of this
technique exist. In this study, which is the largest reported to date, we inves-
tigate the results of the AAAVg conﬁguration.
Methods: At our institution, an AAAVg is a polytetraﬂuoroethylene
(PTFE) graft in a loop conﬁguration in the upper chest with anastomoses
to the axillary artery and ipsilateral axillary vein. After Investigational Review
